Harnessing Biomarker Signatures for Phenotypic Stratification in IBD: Leveraging a Precision Medicine approach to maximize the mechanistic potential of ESN-X

Time: 11:30 am
day: Conference Day Two


  • Deep molecular phenotyping addresses the complexities of the underlying biology in IBD.
  • Multi-omics and machine learning enable identification of patients most likely to benefit from specific drugs.